The Value of Transrectal Ultrasound in the Diagnosis of Hematospermia in a Large Cohort of Patients

The Value of Transrectal Ultrasound in the Diagnosis of Hematospermia in a Large Cohort of Patients
复制标题

经直肠超声在大群体血精诊断中的价值

DOI:
10.2164/jandrol.111.013318
复制
发表时间:
2012-09-01
影响因子:
--
通讯作者:
Chen, Wei
Chen, Wei
中科院分区:
其他
文献类型:
--
作者:
Zhao, Hongwei;Luo, Junhang;Chen, Wei

文献摘要

被引文献

相似文献

经直肠超声检查(TRUS)是一种有效的检查方法,但以往文献报道的患者均少于60例。本文对270例血精症患者进行了经直肠超声检查,以评价其在血精症病因诊断中的作用。患者的年龄范围为15至75岁((x)超过标准,41.2岁),症状持续时间为1天至8年(x)超过标准,3.4个月)。256例(94.8%)患者经TRUS检查发现异常。病变部位:精囊腺125例(46.3%),射精管80例(29.6%),前列腺149例(55.2%),膀胱1例(0.4%)。40岁以上和40岁以下的患者人数分别为126人和144人。结果表明:40岁以上患者恶性病变、前列腺钙化和前列腺增生的发生率明显高于40岁以下患者,270例患者中有8例(3.0%)为恶性肿瘤,且均发生在40岁以上患者。TRUS是一种无创性的,可靠的工具,用于调查血精症的原因。对于年轻患者来说,血精通常是一种良性症状。应特别注意老年患者,以排除恶性肿瘤。
Several studies have proved transrectal ultrasonography (TRUS) is efficient in the evaluation of patients with hematospermia, but the numbers of patients were less than 60 in each of the previous reports. Herein, a total of 270 patients with hematospermia were evaluated by TRUS to assess its efficacy in the etiologic diagnosis of hematospermia. The age of patients ranged from 15 to 75 years ((x) over bar, 41.2 years), and the duration of symptoms was 1 day to 8 years ((x) over bar, 3.4 months). Abnormalities were revealed by TRUS in 256 patients (94.8%). The percentages of pathological conditions located in the seminal vesicles, in the ejaculatory ducts, in the prostate, and in the bladder were 46.3% (125 cases), 29.6% (80 cases), 55.2% (149 cases), and 0.4% (1 case), respectively. The number of patients older than 40 years old and 40 years old or younger were 126 and 144, respectively. Our results show significantly higher percentages for malignant diseases, prostatic calcification and benign prostatic hyperplasia in the group of patients more than 40 years old compared with the group of patients 40 years old or less. Eight of 270 patients (3.0%) had malignant tumors, and all of the 8 malignancies occurred in patients more than 40 years old. TRUS is a noninvasive, reliable tool for the investigation of causes of hematospermia. Hematospermia is generally a benign symptom in younger patients. Special attention should be paid to elderly patients to exclude malignancy.